ClinVar Miner

Submissions for variant NM_000784.4(CYP27A1):c.921G>A (p.Val307=)

gnomAD frequency: 0.00559  dbSNP: rs147975335
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000260899 SCV000427474 likely benign Cholestanol storage disease 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Invitae RCV000260899 SCV001102781 benign Cholestanol storage disease 2024-01-30 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000956039 SCV001144859 benign not provided 2018-10-23 criteria provided, single submitter clinical testing
GeneDx RCV000956039 SCV001822483 likely benign not provided 2021-04-16 criteria provided, single submitter clinical testing
Ambry Genetics RCV002374577 SCV002687908 benign Cardiovascular phenotype 2021-05-21 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Natera, Inc. RCV000260899 SCV001462723 benign Cholestanol storage disease 2019-11-22 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.